As per DelveInsight’s assessment, the DNA Sequencing Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where DNA Sequencing have been used, which is expected to drive the demand for DNA Sequencing in the upcoming years.

DelveInsight’s “DNA Sequencing Market” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.  The report also covers the major emerging products and key DNA Sequencing companies actively working in the market.

DNA Sequencing Overview

Adenine, Guanine, Cytosine, and Thymine are the nucleotide base pairs that make up the majority of genetic information. DNA sequencing is essentially a way to determine the sequence of these base pairs. Understanding this sequence is useful for a variety of tasks, including determining ancestry, choosing a treatment, and diagnosing diseases.

DNA Sequencing Market Insights

The DNA sequencing market is expected to grow due to factors like the increasing prevalence of diseases like cancer and chromosomal disorders that have a genetic component, the growing acceptance of personalized medicine, and the development of newer technologies like third-generation sequencing due to technological advancements. The market for DNA sequencing is anticipated to rise throughout the forecast period (2023–2028) as a result of the increased emphasis on research on infectious diseases, genetics, and medication development in both academia and industry.

DelveInsight Analysis: The Global DNA Sequencing market size is anticipated to reach ~USD 28.85 billion by 2028 with a growing CAGR of 18.02% during the forecasted period (2023-2028).

To know more about why North America is leading the market growth in the DNA Sequencing market, get a snapshot of the report DNA Sequencing Market Trends

https://www.delveinsight.com/report-store/dna-sequencing-market

Recent Developments in the DNA Sequencing Market Report

• In May 2020, F. Hoffman La Roche Ltd. acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche’s nanopore sequencer.
• In January 2020, Agilent Technologies introduced a new product designed to address key challenges that laboratories encounter when preparing DNA sequencing libraries for their research. The new Agilent SureSelect XT HS2 DNA Kit represents the state-of-the-art in library preparation and target enrichment, offering researchers a complete solution that allows them to choose workflow options that best suit their needs.

To read more about the latest highlights related to DNA Sequencing, get a snapshot of the key highlights entailed in the DNA Sequencing Market Forecast Report

Key Players in the DNA Sequencing Market

Some of the key market players operating in the DNA Sequencing market include- Agilent Technologies Inc., Biorad Laboratories Ltd, Danaher Corporation, F. Hoffmann-La Roche Ltd, Illumina Inc, PerkinElmer Inc, Merck & Co., Inc, QIAGEN, Thermo Fisher Scientific, PacBio, Macrogen Inc, Oxford Nanopore Technologies plc, CD Genomics, Takara Bio Inc, Promega Corporation, BGI, 10x Genomics, Eurofins Genomics, GENEWIZ (Azenta Life Sciences), and others.

COVID-19 Impact Analysis on the DNA Sequencing Market

North America is predicted to have the most revenue share in the global DNA sequencing market out of all the regions. This can be attributed, among other things, to the region’s high cancer prevalence and a regulatory climate that is favorable. Additionally, a region’s high disposable income, advanced healthcare infrastructure, and growing public knowledge of novel sequencing initiatives and methodologies are all anticipated to support the expansion of the DNA sequencing industry.

Additionally, Precision medicine’s expanding importance in cancer treatment is a major factor in DNA sequencing’s rising popularity. A novel strategy for managing cancer is the idea of “precision medicine,” which involves tailoring the treatment regimen to the biological characteristics of the tumor. Precision medicine has a wide range of therapeutic applications, including diagnostics, prognosis, early detection of metastasis and recurrence, therapy response and resistance prediction, and biologic cancer stratification. So, during the projected period, the market for DNA Sequencing is anticipated to continue expanding (2023-2028).

Scope of the DNA Sequencing Market Report

• Coverage: Global
• Study Period: 2020–2028
• DNA Sequencing Market Segmentation By Products and Services: Instruments, Consumables, And Services
• DNA Sequencing Market Segmentation By Technology: Sanger Sequencing, Next-Generation Sequencing, And Long-Read Sequencing
• DNA Sequencing Market Segmentation By Application: Disease Diagnosis, Precision Medicine, And Research
• DNA Sequencing Market Segmentation By End User: Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical Companies, And Academic Institutes, And Others
• DNA Sequencing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key DNA Sequencing Companies: Agilent Technologies Inc., Biorad Laboratories Ltd, Danaher Corporation, F. Hoffmann-La Roche Ltd, Illumina Inc, PerkinElmer Inc, Merck & Co., Inc, QIAGEN, Thermo Fisher Scientific, PacBio, Macrogen Inc, Oxford Nanopore Technologies plc, CD Genomics, Takara Bio Inc, Promega Corporation, BGI, 10x Genomics, Eurofins Genomics, GENEWIZ (Azenta Life Sciences), and others
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the DNA Sequencing market are set to emerge as the trendsetter explore @ DNA Sequencing Manufacturer

Table of Contents 

Interested in knowing how the DNA Sequencing market will grow by 2028? Click to get a snapshot of the DNA Sequencing Market Analysis

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services